Tagomics Ltd.

https://www.tagomics.com

Tagomics Ltd., a pioneering biomarker discovery and diagnostics company, has developed a novel multiomics platform, Interlace™, which offers a seamless solution for multiomic profiling to unlock disease-associated DNA biomarkers from a range of biological sources. Based in Cambridge, UK, Tagomics was launched in 2021 as a spin out from The University of Birmingham to build upon research led by Dr Robert Neely, the company’s Chief Scientific Officer. The company has since developed a suite of pioneering 'omics' technologies, including its Interlace multiomic platform, which seamlessly combines the Company’s novel approach to epigenomics (studying chemical 'switches' on the genome) with genomics (detecting mutations and other structural variants) and fragmentomics (the analysis of DNA fragmentation patterns in the blood). By integrating these methods and applying advanced data analysis and machine learning, the Tagomics Interlace platform can provide a 360° understanding of human health and disease. The company aims to discover novel disease markers and apply them to advance diagnostic and drug development. To support this mission, Tagomics has successfully raised over £8 million from investors including Calculus Capital, Illumina Ventures, IQ Capital, Agilent Ventures, Mercia Ventures, Meltwind, OMX Ventures, and Start Codon. *

	Start	2020-07-22 established (s-off)
	Predecessor	University of Birmingham
	Industry	multi-omics diagnostics
	Industry 2	Interlace™ multiomics platform (Tagomics)
	Person	Kennefick, Jack (Tagomics 202402 CEO + Co-Founder)

	Region	Cambridge, Cambridgeshire
	Country	United Kingdom (GB)
	City	CB21 6GQ Cambridge, Cambridgeshire
		Address record changed: 2024-11-24

Basic data	Employees	n. a.

		* Document for »About Section«: Tagomics Ltd.. (11/20/24). "Press Release: Tagomics Announces a Multiomic Profiling Co-Marketing Agreement with Agilent". Cambridge.

		Record changed: 2024-11-24

Top News

Upcoming Events

Management Appointments

Financings & Acquisitions

Collaborations & Licensing

At Investor Conferences

Associations

Advertise

Tagomics Ltd.

More documents for Tagomics Ltd.